Final Programme - iuphar

FC13 Maximising benefits and minimizing harms from
drugs
Thu 125 Gentamicin pharmacokinetics estimated using rat model of early sepsis with capillary leak syndrome
Studena Studena, (Czech Republic), J Martinkova, J Chladek, D Slizova, O Krs, J Zahora
Thu 126 Analysis of proarrhythmic effects of typical IKr blockers using human ES/iPS cell-derived
cardiomyocytes
Atsushi Sugiyama, (Japan), T Kitamura, F Nomura, T Kaneko, P Sartipy, K Fukuda, K Yasuda
Thu 127 Routine use of pharmacogenetic tests for detection of CYP2C19 genetic polymorphisms in Clopidogrel
non-responders in resource limited setting
Chonlaphat Sukasem, (Thailand), R Tunthongb, V Pairoj, C Srichunrasamia, P Vathesatogkit, P Sritarab,
W Chantratita
Thu 128 Determination of Olanzapine in human plasma by a validated LC-MS/MS method
Dobrin Svinarov, (Bulgaria), L Kasabova
Thu 129 Reduced activity of CYP2C9 in the application of a complex pharmacotherapy at Russian patients with
decompensation of chronic heart failure
Dmitry A Sychev, (Russian Federation), A Levanov, A Savchenko, G Ramenckaya, V Dmitriev,
S Bogoslovscaya, V Kukes
Thu 130 Investigation of bioavailability of nanosized telmisartan in rat
Anita Sztojkov-Ivanov, (Hungary), G Filipcsei, G Heltovics, F Darvas, I Zupkó
Thu 131 Potentially inappropriate medication leading to adverse drug reactions and hospitalisation
Jacek Szymanski, (Germany), S Schmiedl, S Holt, K Farker, B Drewelow, M Hippius, K May,
PA Thürmann
Thu 132 Cevimeline raises saliva volume and level of substance P in saliva
Masaharu Takeyama, (Japan), K Amada, S Tsuda, Y Sato, H Itoh
Thu 133 Lithium potentiates the effects of thiocolchicoside on neuronal excitability in rat dentate gyrus
Giuseppe Talani, (Italy), N Obili, E Fadda, R Uras, G Cordeddu, C Fois, S Prinzis, A Frau, V Piras,
L Siuni, P Niola, PL De Riu, GP Sechi, G Biggio, E Sanna
Thu 134 Preliminary experimental data regarding the bioavailability and biodistribution of systemically
administered 99MTC-coupled AA124 silica nanoparticle
Bogdan I Tamba, (Romania), C Stefanescu, I Jaba, O Mungiu, A Wirth, U Pieles
Thu 135 Transfection of a mutant mu-opioid receptor into mice periaqueductal gray resulted in naloxonemediated
antinociception without tolerance and dependence
Pao-Luh Tao, (Taiwan), SH Chou, HI Ma, PY Law, HH Loh
Thu 136 Taste perceptions of salbutamol-containing inhalers: A randomised crossover trial
Jolyn Tay, (New Zealand), TR Ingham, B Jones, N Pierse, C Burgess
Thu 137 Delay of monitoring may add to pre-existing toxicity risk in elderly patients treated with potentially
nephrotoxic antibiotics: case series study
Hundie Tesfaye, (Czech Republic), R Prusa, B Jedlickova, J Lukaskova, M Palivoda, V Pavelkova
Thu 138 Effect of losartan on metabolism of arachidonic acid using recombinant cytochrome P450 (CYP)
enzymes
Takaki Toda, (Japan), N Inotsume, K Sakamoto, S Takeuchi, T Hayakawa, B Ask, E Eliasson, A Rane
Thu 139 Dose response for simvastatin in a rat model for the evaluation of myopathy
Brian Tomlinson, (PR China), VWL Mak, TWC Lo, DK Rowlands, M Hu, B Chadwick, AE James
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 289